A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer Comparing Docetaxel Plus Fulvestrant With Docetaxel in Patients With Metastatic Breast Cancer

• Country None
• organs None
• Specialty None

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis Comparing Dexamethasone, Aprepitant and Mirtazapine With Dexamethasone and Aprepitant in Delayed Emesis Control and Appetite Improvement

• Country China
• organs None
• Specialty None

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer Abraxane in patients with visceral metastases dominant metastatic breast cancer

• Country None
• organs None
• Specialty None

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis The primary objective of this study is to evaluate the effects of Zometa (zoledronic acid, 1 mg per week versus 4 mg every four weeks) on the circulating vascular endothelial growth factor...

• Country None
• organs None
• Specialty None

Fulvestrant 500mg in Patients With Advanced Breast Cancer Fulvestrant 500mg in Patients With Advanced Breast Cancer

• Country None
• organs None
• Specialty None

Platinum Rechallenge in Patients With Platinum-sensitive mTNBC Platinum Retreated in Patients with Platinum Sensitive mTNBC

• Country None
• organs None
• Specialty None

Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)

• Country None
• organs None
• Specialty None

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

• Country None
• organs None
• Specialty None